
Applied DNA Launches Monkeypox Testing Service
September 6th, 2022
Applied DNA Launches Monkeypox Testing Service
September 6th, 2022
APDN Submits PCR-based Monkeypox Diagnostic Test to NYS Dept of Health
August 19th, 2022
APDN Initiates Validation of PCR-based Monkeypox Diagnostic Test
August 2nd, 2022
APDN Announces Continued Momentum in COVID-19 Testing Demand
January 18th, 2022
APDN Receives CLIA Certification, Enabling High Throughput COVID-19 Testing
May 11th, 2021
New Highly Sensitive COVID-19 Clinical Test Now in Use at Stony Brook
May 18th, 2020
Applied DNA High-Sensitivity and High-Throughput COVID-19 Diagnostic Kit Enters Validation Process in Partnership with Stony Brook University Hospital
April 21st, 2020
Provisional Patent Application Filed for High Sensitivity COVID-19 Diagnostic Assay
March 24th, 2020
Applied DNA Leverages COVID-19 Vaccine Development and Proprietary Linear DNA Manufacturing Capability to Design a High Sensitivity Diagnostic Kit for Virus Detection
March 19th, 2020